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Cyclosporine Characterization
Powder X-ray diffraction (PXRD) data was collected on a Bruker D8 Advance equipped with a Lynxeye linear position sensitive detector (Bruker AXS, Madison, WI). Crude cyclosporine (CC*) and pure cyclosporine (commercial) were smeared directly onto the silicon wafer of a proprietary low-background sample holder. Data was collected using a continuous coupled θ/2θ scan with Ni-filtered Cu-Kα radiation ( Figure S1 
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Figure S1
. PXRD data comparison on pure (blue) and crude (pink) cyclosporine.
Thermogravimetric Analysis (TGA) was performed on a TA Instruments (New Castle, DE) model 2950 thermogravimetric analyzer ( Figure S2 ). The experiments were performed under a nitrogen atmosphere. Five to ten mg cyclosporine were placed in a platinum pan and heated from 25 °C to 800 °C with a heating rate of 5 °C min −1 . 
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Synthesis of the ILs
n-Butylammonium acetate and n-octylammonium acetate: n-Butylamine (50 mmol, 4.97 mL, 99.5% purity) or n-octylamine (50 mmol, 99.0% purity, 6.5271 g) was placed in a 2-neck round bottom flask (25 mL), containing a Teflon-coated magnetic stirrer. The flask was cooled in a cold ice-water bath to ca. 0 °C while magnetically stirring. A condenser was placed on the top of the flask. The other neck of the flask was covered with a rubber septa. Glacial acetic acid (50 mmol, 2.9 mL) was then slowly (drop-wise) added through the neck of the flask covered with the rubber septum, using a syringe. Although the formation of fumes was observed in the flask during addition of glacial acetic acid, no fumes or condensation was observed on the condenser. After complete addition of glacial acetic acid, the stirring continued for 6 h under reflux at room temperature. After 6 h, the condenser was removed, and the solution was stirred overnight at room temperature. Any excess of acetic acid was eliminated using rotavapor (R-210, Büchi, Switzerland) for 6 h. In the case of n-butylammonium acetate, a liquid was obtained; while n-octylammonium acetate solidified when cooled to room temperature.
1H-NMR was used to confirm the composition of the synthesized IL ( Figure S3 and S4). The spectra were recorded using DMSO-d6 as the lock solvent. 1H NMR spectra were recorded using a Bruker Ascend TM 500 (Madison, WI, USA) spectrometer operating at 500 MHz. Figure S3 . 1H-NMR spectra of n-butylammonium acetate. Figure S4 . 1H-NMR spectra of n-octylammonium acetate.
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Choline Acetate: Briefly, acetic acid (0.1 mol) was added dropwise into an aqueous solution of choline hydroxide (0.1 mol). The mixture was stirred continuously using a magnetic stirrer for 12 h at room temperature (~22 °C). The obtained IL was dried for 6 h under vacuum using a rotary evaporator (R-210, Büchi, Switzerland), followed by freeze drying (Free zone 2.5, Labconco, USA) for 4 days. 500 MHz Nuclear Magnetic Resonance (NMR, AVIIIHD 500, Bruker, Switzerland) spectroscopy was used to confirm the identity and purity of the 
